Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Prepaid Assets: 2015-2025

Historic Prepaid Assets for Editas Medicine (EDIT) over the last 10 years, with Sep 2025 value amounting to $3.1 million.

  • Editas Medicine's Prepaid Assets fell 47.46% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 47.46%. This contributed to the annual value of $3.1 million for FY2024, which is 58.36% down from last year.
  • According to the latest figures from Q3 2025, Editas Medicine's Prepaid Assets is $3.1 million, which was down 16.02% from $3.7 million recorded in Q2 2025.
  • In the past 5 years, Editas Medicine's Prepaid Assets registered a high of $9.5 million during Q3 2021, and its lowest value of $3.1 million during Q3 2025.
  • For the 3-year period, Editas Medicine's Prepaid Assets averaged around $5.6 million, with its median value being $5.9 million (2024).
  • Per our database at Business Quant, Editas Medicine's Prepaid Assets surged by 58.20% in 2024 and then tumbled by 63.14% in 2025.
  • Quarterly analysis of 5 years shows Editas Medicine's Prepaid Assets stood at $7.2 million in 2021, then grew by 1.90% to $7.3 million in 2022, then climbed by 2.67% to $7.5 million in 2023, then tumbled by 58.36% to $3.1 million in 2024, then crashed by 47.46% to $3.1 million in 2025.
  • Its Prepaid Assets stands at $3.1 million for Q3 2025, versus $3.7 million for Q2 2025 and $3.4 million for Q1 2025.